CCR5 receptor -: Biologic and genetic implications in age-related diseases

被引：53

作者：

Balistreri, Carmela Rita ^{[1
]}

Caruso, Calogero ^{[1
]}

Grimaldi, Maria Paola ^{[1
]}

Listi, Florinda ^{[1
]}

Vasto, Sonya ^{[1
]}

Orlando, Valentina ^{[1
]}

Campagna, Anna Maria ^{[1
]}

Lio, Domenico ^{[1
]}

Candore, Giuseppina ^{[1
]}

机构：

[1] Univ Palermo, Dipartimento Biopatol & Metodol Biomed, Grp Studio Sull Immunosenescenza, I-90134 Palermo, Italy

来源：

BIOGERONTOLOGY: MECHANISMS AND INTERVENTIONS | 2007年 / 1100卷

关键词：

Alzheimer's disease; aging; cardiovascular disease; CCR5;

D O I：

10.1196/annals.1395.014

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The CC chemokine receptor 5 (CCR5) is a member of CC-chemokine receptor family. CCR5 has the characteristic structure of a seven transmembrane G protein-coupled receptor (GPCR), which regulates trafficking and effector functions of memory/effector Thl cells, macrophages, NK cells, and immature dendritic cells. CCR5 and its ligands are important molecules in viral pathogenesis. CCR5 represents the co-receptor for macrophage (M) and dual (T cell and M)-tropic immunodeficiency viruses. Recent evidence has also demonstrated the role of CCR5 in a variety of human diseases, ranging from infectious and inflammatory diseases to cancer. In this article, we describe the involvement of CCR5 in two age-related diseases, atherosclerosis and Alzheimer's disease, suggesting a possible role of chemokine system on these diseases' pathophysiology. Finally, we review the data on the probable association between CCR5 Delta 32 deletion and cardiovascular diseases and Alzheimer's disease.

引用

页码：162 / 172

页数：11

共 49 条

[1] CC CKRS: A RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1
Alkhatib, G
Combadiere, C
Broder, CC
Feng, Y
Kennedy, PE
Murphy, PM
Berger, EA
[J]. SCIENCE, 1996, 272 (5270) : 1955 - 1958
[2] Apostolakis S, 2006, INT J MOL MED, V17, P691
[3] Association between the polymorphism of CCR5 and Alzheimer's disease - Results of a study performed on male and female patients from Northern Italy
Balistreri, Carmela Rita
Grimaldi, Maria Paola
Vasto, Sonya
Listi, Florinda
Chiappelli, Martina
Licastro, Federico
Lio, Domenico
Caruso, Calogero
Candore, Giuseppina
[J]. ESTROGENS AND HUMAN DISEASES, 2006, 1089 : 454 - 461
[4] CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis
Barcellos, LF
Schito, AM
Rimmler, JB
Vittinghoff, E
Shih, A
Lincoln, R
Callier, S
Elkins, MK
Goodkin, DE
Haines, JL
Pericak-Vance, MA
Hauser, SL
Oksenberg, JR
[J]. IMMUNOGENETICS, 2000, 51 (4-5) : 281 - 288
[5] The CCR5 deletion mutation fails to protect against multiple sclerosis
Bennetts, BH
Teutsch, SM
Buhler, MM
Heard, RNS
Stewart, GJ
[J]. HUMAN IMMUNOLOGY, 1997, 58 (01) : 52 - 59
[6] CXC and CC chemokine receptors on coronary and brain endothelia
Berger, O
Gan, XH
Gujuluva, C
Burns, AR
Sulur, G
Stins, M
Way, D
Witte, M
Weinand, M
Said, J
Kim, KS
Taub, D
Graves, MC
Fiala, M
[J]. MOLECULAR MEDICINE, 1999, 5 (12) : 795 - 805
[7] Distribution of α1-antitrypsin PI S and PI Z frequencies in countries outside Europe:: a meta-analysis
Blanco, I
Bustillo, EF
Rodriguez, MC
[J]. CLINICAL GENETICS, 2001, 60 (06) : 431 - 441
[8] CCR5 genotyping in an Australian and New Zealand type 1 diabetes cohort
Buhler, MM
Craig, M
Donaghue, KC
Badhwar, P
Willis, J
Manolios, N
Tait, BD
Silink, M
Bennetts, BH
Stewart, GJ
[J]. AUTOIMMUNITY, 2002, 35 (07) : 457 - 461
[9] The role of chemokines in atherosclerosis: recent evidence from experimental models and population genetics
Bursi, CA
Channon, KM
Greaves, DR
[J]. CURRENT OPINION IN LIPIDOLOGY, 2004, 15 (02) : 145 - 149
[10] Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases
Cartier, L
Hartley, O
Dubois-Dauphin, M
Krause, KH
[J]. BRAIN RESEARCH REVIEWS, 2005, 48 (01) : 16 - 42

← 1 2 3 4 5 →